Flagship-backed Evelo Biosciences joins Covid-19 hunt with proposal for bacteria trial
A Flagship-backed biotech wants to fight the microbe now ravaging much of the earth with another microbe.
Today, Evelo Biosciences announced they filed an IND …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
